{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:55:26Z","timestamp":1791050126998,"version":"4.1.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"DOI":"10.1210\/jc.2008-2640","type":"journal-article","created":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T21:58:53Z","timestamp":1243375133000},"page":"2766-2772","source":"Crossref","is-referenced-by-count":125,"title":["Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"94","author":[{"given":"Claudio","family":"Marcocci","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism (C.M.), University of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Reproductive Diseases (P.C.), Assistance Publique-Ho\u0302pitaux de Paris, Ho\u0302pital de Bice\u0302tre and Universite\u0301 Paris-Sud 11, 94275 Le Kremlin-Bice\u0302tre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Shoback","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit (D.S.), San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California, San Francisco, California 94143"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"College of Physicians and Surgeons (J.B.), Columbia University, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureano","family":"Fernandez-Cruz","sequence":"additional","affiliation":[{"name":"University of Barcelona (L.F.-C.), 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Orgiazzi","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie-Diabe\u0301tologie (J.O.), Centre Hospitalier Lyon Sud, Universite\u0301 Claude-Bernard Lyon-1, 69495 Pierre-Be\u0301nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Henzen","sequence":"additional","affiliation":[{"name":"Endokrinologie-Diabetologie Kantonsspital (C.H.), Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunfa","family":"Cheng","sequence":"additional","affiliation":[{"name":"Amgen Inc. (S.C., L.R.S., J.L.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu Ren","family":"Sterling","sequence":"additional","affiliation":[{"name":"Amgen Inc. (S.C., L.R.S., J.L.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lu","sequence":"additional","affiliation":[{"name":"Amgen Inc. (S.C., L.R.S., J.L.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munro","family":"Peacock","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine (M.P.), Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113561942800_R1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4158\/EP.11.1.49","article-title":"The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism.","volume":"11","year":"2005","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113561942800_R2","first-page":"S83","article-title":"Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology","author":"Heath 3rd","year":"1991","journal-title":"J Bone Miner Res 6(Suppl 2):S63\u2013S70; discussion"},{"key":"key\n\t\t\t\t2019041113561942800_R3","first-page":"1002","article-title":"The evolution of parathyroidectomy failures","author":"Boggs","year":"1999","journal-title":"Surgery 126:998\u20131002; discussion"},{"key":"key\n\t\t\t\t2019041113561942800_R4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00268-002-6664-2","article-title":"Quality of life and patient satisfaction after reoperation for primary hyperparathyroidism: analysis of long-term results.","volume":"26","author":"Hasse","year":"2002","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113561942800_R5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/eje.0.1480413","article-title":"Recurrence of hyperparathyroidism: a long-term follow-up after surgery for primary hyperparathyroidism.","volume":"148","author":"Hedback","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113561942800_R6","first-page":"N158","article-title":"Recurrent or persistent hyperparathyroidism","volume":"17","author":"Wells Jr","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113561942800_R7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl.","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041113561942800_R8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113561942800_R9","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113561942800_R10","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113561942800_R11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113561942800_R12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\u00ae\/Mimpara\u00ae) treatment algorithm for secondary hyperparathyroidism.","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113561942800_R13","unstructured":"Amgen Inc. 2008Sensipar\u00ae (cinacalcet) tablets. U.S. prescribing information. http:\/\/www.sensipar.com\/professional\/pdf\/sensipar_pi.pdf."},{"key":"key\n\t\t\t\t2019041113561942800_R14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/0091270007304103","article-title":"Effect of cinacalcet hydrochloride, a new calcimietic agent, on the pharmacokinetics of dextromethorphan: in vitro and clinical studies.","volume":"47","author":"Nakashima","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041113561942800_R15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cpt1978242219","article-title":"Salmon calcitonin in hypercalcemia.","volume":"24","author":"Wisneski","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041113561942800_R16","first-page":"1959","article-title":"A practical approach to hypercalcemia.","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t2019041113561942800_R17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0039-6060(99)70224-2","article-title":"Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels.","volume":"125","author":"Burney","year":"1999","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019041113561942800_R18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1067\/msy.2000.110844","article-title":"Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey","volume":"128","author":"Talpos","year":"2000","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019041113561942800_R19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.","volume":"51","author":"Ware Jr","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041113561942800_R20","first-page":"102","article-title":"Psychological distress\/well-being and cognitive functioning measures","author":"Stewart","year":"1992","journal-title":"In: Stewart AL, Ware JE, eds. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University;"},{"key":"key\n\t\t\t\t2019041113561942800_R21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00019053-200018050-00001","article-title":"The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?","volume":"18","author":"Hays","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"key\n\t\t\t\t2019041113561942800_R22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113561942800_R23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism.","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113561942800_R24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism.","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113561942800_R25","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113561942800_R26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<125::AID-SSU8>3.0.CO;2-B","article-title":"Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism.","volume":"13","author":"Tanaka","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"key\n\t\t\t\t2019041113561942800_R27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0039-6060(97)90328-7","article-title":"Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.","volume":"122","author":"Thorsen","year":"1997","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019041113561942800_R28","first-page":"1026","article-title":"Surgical treatment of hyperparathyroidism improves health-related quality of life","author":"Sheldon","year":"2002","journal-title":"Arch Surg 137:1022\u20131026; discussion"},{"key":"key\n\t\t\t\t2019041113561942800_R29","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00268-007-9006-6","article-title":"Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism.","volume":"31","author":"Weber","year":"2007","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113561942800_R30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up).","volume":"141","author":"Caillard","year":"2007","journal-title":"Surgery"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/8\/2766\/9064488\/jcem2766.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T06:29:59Z","timestamp":1558333799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/8\/2766\/2596535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2640","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164562.626334","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]}}}